StabilityStudies.in
Standard Operating Procedure for Stability Testing of Single-Dose Vials
1) Purpose
The purpose of this SOP is to establish a procedure for conducting stability studies on single-dose vials, ensuring that the drug product maintains its quality, potency, and sterility throughout its shelf life.
2) Scope
This SOP applies to all single-dose vial drug products manufactured, tested, or stored within the facility. It covers the responsibilities of departments involved in production, quality control, quality assurance, and regulatory compliance.
3) Responsibilities
- Quality Control (QC) Team: Conducts stability tests, including sterility, potency, and physical examination.
- Quality Assurance (QA) Team: Reviews and approves the stability study protocol and final reports.
- Production Team: Provides necessary samples and maintains records of batch production.
4) Procedure
- Sample Collection and Preparation
- Collect representative samples from single-dose vial production batches.
- Ensure samples are stored under the appropriate conditions until the stability study begins.
- Development of Stability Study Protocol
- Draft a protocol outlining the storage conditions, testing intervals, and analytical methods (e.g., sterility testing, potency assays).
- Submit the protocol for approval to the QA and Regulatory Affairs teams.
- Conducting the Stability Study
- Store samples in designated stability chambers under controlled conditions (e.g., 25°C/60% RH).
- Perform analytical tests at each specified interval to assess sterility, potency, and physical characteristics.
- Document all test results, observations, and any deviations from the protocol.
- Data Analysis and Reporting
- Analyze the stability data to determine if the single-dose vial product meets the acceptance criteria over time.
- Prepare a detailed stability study report and submit it to the QA team for review and approval.
5) Abbreviations, if any
- QC: Quality Control
- QA: Quality Assurance
- RH: Relative Humidity
6) Documents, if any
- Stability Study Protocol
- Analytical Test Reports
- Stability Study Report
7) Reference, if any
- ICH Q1A(R2): Stability Testing of New Drug Substances and Products
- USP General Chapter <797>: Pharmaceutical Compounding – Sterile Preparations
8) SOP Version
Version 1.0
StabilityStudies.in